Accurately characterized optical tissue phantoms: how, why and when?

Jean-Pierre Bouchard; Israël Veilleux; Isabelle Noiseux; Ozzy Mermut

doi:10.1117/12.875400

10 February 2011 Accurately characterized optical tissue phantoms: how, why and when?

Jean-Pierre Bouchard, Israël Veilleux, Isabelle Noiseux, Ozzy Mermut

Proceedings Volume 7906, Optical Diagnostics and Sensing XI: Toward Point-of-Care Diagnostics; and Design and Performance Validation of Phantoms Used in Conjunction with Optical Measurement of Tissue III; 79060K (2011) https://doi.org/10.1117/12.875400
Event: SPIE BiOS, 2011, San Francisco, California, United States

Abstract

Optical tissue phantoms are very important tools for the development of biomedical imaging applications. Optical phantoms are often used as ground truth against which instruments results can be compared. It is therefore important that the optical properties of reference phantoms be measured in a manner that is traceable to the international system of units. SI traceability insures long term consistency of results and will therefore improve the effectiveness of diffuse optics research effort more effective by reducing unwanted variability in the data produced and shared by the community. The ultimate benefit of rigorous SI traceability is the reduction of variability in the data produced by novel diagnostic devices, which will in turn increase the statistical power of clinical trials aiming at validating their clinical usefulness. SI traceability, and therefore uncertainty analysis, is also relevant to traceability aspects mandated by FDA regulations. SI traceability is achieved through a thorough analysis of the measurement principle and its potential error sources. The uncertainty analysis should be ultimately validated by inter-laboratory comparison until a consensus is attained on the best practices for measuring the optical properties of tissue phantoms.

Citation Download Citation

Jean-Pierre Bouchard, Israël Veilleux, Isabelle Noiseux, and Ozzy Mermut "Accurately characterized optical tissue phantoms: how, why and when?", Proc. SPIE 7906, Optical Diagnostics and Sensing XI: Toward Point-of-Care Diagnostics; and Design and Performance Validation of Phantoms Used in Conjunction with Optical Measurement of Tissue III, 79060K (10 February 2011); https://doi.org/10.1117/12.875400

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available